McKesson Corporation (MCK)

Return on equity (ROE)

Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net income US$ in thousands 3,295,000 3,002,000 3,560,000 1,114,000 -4,339,000
Total stockholders’ equity US$ in thousands -2,074,000 -1,971,000 -1,857,000 -2,272,000 -21,000
ROE

March 31, 2025 calculation

ROE = Net income ÷ Total stockholders’ equity
= $3,295,000K ÷ $-2,074,000K
= —

Based on the provided data, the return on equity (ROE) for McKesson Corporation is not available for the years ended March 31, 2021 through 2025. This lack of specific ROE data makes it challenging to assess the company's profitability in relation to the equity invested by shareholders during these years. ROE is a key financial metric that indicates how efficiently a company is generating profits from its shareholders' equity.

It is important to note that without the ROE figures, it is difficult to evaluate McKesson Corporation's performance in terms of generating returns for its shareholders and how effectively the company is utilizing shareholder equity to generate profits. Investors and analysts usually rely on ROE to understand a company's financial health and compare it to industry peers.

In the absence of specific ROE data, further analysis or additional financial metrics would be required to provide a comprehensive assessment of McKesson Corporation's performance and profitability over the indicated years.


Peer comparison

Mar 31, 2025

Company name
Symbol
ROE
McKesson Corporation
MCK
Cardinal Health Inc
CAH
Cencora Inc.
COR
233.63%

See also:

McKesson Corporation Return on Equity (ROE)